Overview

Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The investigators study the efficacy and safety of tacrolimus in the treatment of membranous nephritis secondary to systemic lupus erythematosus.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese University of Hong Kong
Treatments:
Tacrolimus